Rain Therapeutics

$2.28 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Rain Therapeutics

Rain Therapeutics Inc. operates as a clinical stage biotechnology company. The Company develops and produces biomarker-driven small molecule therapeutics for patients with cancer and other related diseases. Rain Therapeutics serves customers worldwide.

Stock Analysis

last close $2.28
1-mo return -44.8%
3-mo return -63.9%
avg daily vol. 65.28T
52-week high 22.22
52-week low 2.2
market cap. $50M
forward pe -
annual div. -
roe -176.9%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 83.6%

Subscribe now for daily local and international financial news